Battisti, Nicolò Matteo Luca http://orcid.org/0000-0002-1063-1717
Andres, Maria Sol
Lee, Karla A.
Ramalingam, Sivatharshini
Nash, Tamsin
Mappouridou, Stephanie
Senthivel, Nishanthi
Asavisanu, Kalaprapa
Obeid, Mariam
Tripodaki, Elli-Sophia
Angelis, Vasileios
Fleming, Emily
Goode, Emily F.
John, Susan
Rosen, Stuart D.
Allen, Mark
Stanway, Susannah
Lyon, Alexander R.
Ring, Alistair http://orcid.org/0000-0003-1230-2973
Article History
Received: 17 February 2021
Accepted: 10 March 2021
First Online: 5 April 2021
Declarations
:
: Dr. Battisti has received travel grants from Genomic Health and Pfizer and speaker fees from Pfizer and AbbVie. Dr. Lyon has received speaker, advisory board or consultancy fees and/or research grants from Pfizer, Novartis, Servier, Astra Zeneca, Bristol Myers Squibb, GSK, Amgen, Takeda, Roche, Janssens-Cilag Ltd, Clinigen Group, Eli Lily, Eisai Ltd, Ferring Pharmaceuticals, Boehringer Ingelheim, Akcea Therapeutics, Myocardial Solutions, iOWNA Health and Heartfelt Technologies Ltd. Dr. Ring has received advisory board and speaker fees from Roche, Novartis, Pfizer, MSD and Lilly. Dr. Andres, Dr. Lee, Dr Ramalingam, Dr. Nash, Dr Mappouridou, Dr. Senthivel, Dr. Asavisanu, Dr. Obeid, Dr. Tripodaki, Dr. Angelis, Dr. Fleming, Dr. Goode, Dr. John, Professor Rosen, Dr. Allen, Dr. Stanway have no conflicts of interest.
: This analysis was approved as a Service Evaluation by The Committee for Clinical Review of The Royal Marsden NHS Foundation Trust.
: No individual person’s data are included in the manuscript in any form and therefore no consents for publication were required.